NCT02577900 (DFU) is a NA clinical trial of Acticoat absorbent in Diabetic Foot, sponsored by Queen Elizabeth Hospital, Hong Kong.

Who is sponsoring NCT02577900?

NCT02577900 is sponsored by Queen Elizabeth Hospital, Hong Kong.

What drugs are being tested in NCT02577900?

Interventions in NCT02577900: Acticoat absorbent, Honey gel sheet, Jelonet.

What condition does NCT02577900 study?

NCT02577900 studies Diabetic Foot.

Is NCT02577900 still recruiting?

NCT02577900 is currently completed. Last updated 5 April 2019.

Are results published for NCT02577900?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2019-04-05 · How we verify

NCT02577900: DFU

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Randomized, Controlled Study of Nanocrystalline Silver, Manuka Honey and Conventional Dressing in Healing Diabetic Foot Ulcer

Completed NA Results posted Last updated 5 April 2019

What this trial tests

NA trial testing Acticoat absorbent in Diabetic Foot in 31 participants. Completed in 1 August 2015.

Timeline

1 February 2013

Primary endpoint
1 August 2015

1 August 2015

Quick facts

Lead sponsor	Queen Elizabeth Hospital, Hong Kong
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	31
Start date	1 February 2013
Primary completion	1 August 2015
Estimated completion	1 August 2015

Drugs / interventions tested

Acticoat absorbent
Honey gel sheet
Jelonet

Conditions studied

Diabetic Foot — all drugs for Diabetic Foot →

Sponsor

Queen Elizabeth Hospital, Hong Kong

Who can join

Adults 40 to 85, any sex, with Diabetic Foot. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Number of Participants With Complete Healing of Ulcer During the Observation Period
Time frame: 12 weeks
The number of participants have absence of a visible wound achieved by complete epithelialization

Sponsor's own description

The purpose of this study is to determine whether nanocrystalline silver dressing, manuka honey dressing and conventional dressing are effective in the treatment of diabetic foot ulcer.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A Pilot Randomized, Controlled Study of Nanocrystalline Silver, Manuka Honey, and Conventional Dressing in Healing Diabetic Foot Ulcer.
Tsang KK, Kwong EW, To TS, Chung JW, et al · · 2017 · cited 27× · PMID 28239398 · DOI 10.1155/2017/5294890
Evidence for Natural Products as Alternative Wound-Healing Therapies.
Moses RL, Prescott TAK, Mas-Claret E, Steadman R, et al · · 2023 · cited 17× · PMID 36979379 · DOI 10.3390/biom13030444

Verify or expand the search:

Other recruiting trials for Diabetic Foot

Currently open trials in the same condition.

NCT06487780 — Evaluating a Lifestyle Intervention to Prevent Recurrence of Diabetic Foot Ulcers · NA · recruiting
NCT06674980 — Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DF · NA · recruiting
NCT06760416 — Online Diabetic Foot Support Program- Care Kit · NA · active not recruiting
NCT06552910 — Analyzing Anesthetic Techniques in Diabetic Foot Amputation · recruiting
NCT06526936 — The Effect of Foot Care Training Given to Diabetic Hemodialysis Patients on Foot Care Behavior · NA · recruiting

Other Queen Elizabeth Hospital, Hong Kong trials

Trials by the same sponsor.

NCT04474002 — Efficacy, Tolerance and Safety of Split Dose Bowel Preparation for Colonoscopy: 4L Polyethylene Glycol (PEG) Versus 1L P · Phase 4 · completed
NCT03082092 — Pre-operative Intravenous Steroid in Total Knee Replacement for Pain Relief and Recovery · Phase 4 · completed
NCT03909841 — Neuropathic Pain in Elderly People With Diabetes: Impact on Quality of Life and Cognition · completed
NCT03814369 — AmplifEYE Colonoscopy vs Standard Colonoscopy · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02577900 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Queen Elizabeth Hospital, Hong Kong
Last refreshed: 5 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02577900.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing